N-{4-[4-(4-chlorobenzenesulfonyl)piperazin-1-yl]-3-fluorophenyl}acetamide

Catalog No.: 
ACPRKY070
CAS No.: 
866131-34-2
Molecular Formula: 
C18H19ClFN3O3S
Molecular Weight: 
411.89
N-{4-[4-(4-chlorobenzenesulfonyl)piperazin-1-yl]-3-fluorophenyl}acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$103.00InquiryInquiry
1g90%$323.00InquiryInquiry
5g90%$1583.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-{4-[4-(4-chlorobenzenesulfonyl)piperazin-1-yl]-3-fluorophenyl}acetamide
IUPAC NameN-(4-(4-((4-chlorophenyl)sulfonyl)piperazin-1-yl)-3-fluorophenyl)acetamide
Molecular FormulaC18H19ClFN3O3S
Molecular Weight411.89
SMILESCC(NC1=CC=C(N2CCN(S(=O)(C3=CC=C(Cl)C=C3)=O)CC2)C(F)=C1)=O
InChI KeyNJDZIOFHTQRDDB-UHFFFAOYSA-N
SynonymN-{4-[4-(4-chlorobenzenesulfonyl)piperazin-1-yl]-3-fluorophenyl}acetamide;Acetamide, N-[4-[4-[(4-chlorophenyl)sulfonyl]-1-piperazinyl]-3-fluorophenyl]-
CAS No.866131-34-2

Synthetic Route by SureRoute

1. ACPRKY070 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPRKY070 route product structure diagram
    ACPRKY070866131-34-2
Inquiry

2. ACPRKY070 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPRKY070 route product structure diagram
    ACPRKY070866131-34-2
Inquiry

3. ACPRKY070 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPRKY070 route product structure diagram
    ACPRKY070866131-34-2
Inquiry

Comments (0)